נקסין 250 מ"ג

Ülke: İsrail

Dil: İbranice

Kaynak: Ministry of Health

Aktif bileşen:

NAPROXEN 250 MG

Mevcut itibaren:

TEVA PHARMACEUTICAL INDUST.LTD

ATC kodu:

M01AE02

Farmasötik formu:

TABLETS

Uygulama yolu:

PER OS

Tarafından üretildi:

TEVA PHARMACEUTICAL INDUSTRIES LTD

Terapötik grubu:

NAPROXEN

Terapötik endikasyonlar:

- Relief of the signs and symptoms of rheumatic diseases including osteoarthritis, ankylosing spondylitis of rheumatoid arthritis, both in the treatment of acute flares and in the long-term management of the disease. - Juvenile Rheumatoid Arthritis. - Periarticular and Musculoskeletal Disorders.- Relief of pain in bursitis, tendinitis, synovitis, tenosynovitis and lumbago. - Relief of pain, swelling, tenderness and fever in acute gouty arthritis. - Relief of symptoms of primary dysmenorrhea.

Yetkilendirme tarihi:

2009-05-01